首页> 美国卫生研究院文献>Annals of Translational Medicine >Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?
【2h】

Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?

机译:临床实践中的冠状动脉钙化:我们了解到了什么为什么要在胸部CT上常规报告?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The recent acceptance of low dose chest computed tomography (LDCT) as a screening modality for early lung cancer detection will significantly increase the number of LDCT among high risk population. The target subjects are at the same time at high risk to develop cardiovascular (CV) events. The routine report on coronary artery calcification (CAC) will therefore, enhances the screening benefit by providing the clinicians with an additive powerful risk stratification tool for the management or primary prevention of CV events. This review will provide the radiologists with helpful information for the daily practice regarding on what is CAC, its clinical applications and how to diagnose, quantify and report on CAC while reading the LDCT.
机译:最近接受低剂量胸部计算机断层扫描(LDCT)作为早期肺癌检测的筛查手段将大大增加高危人群中LDCT的数量。目标受试者同时处于发展心血管(CV)事件的高风险中。因此,有关冠状动脉钙化(CAC)的常规报告将通过为临床医生提供用于管理或初步预防CV事件的附加强大的风险分层工具来增强筛查的益处。这篇综述将为放射科医生提供有关什么是CAC,其临床应用以及在阅读LDCT时如何诊断,量化和报告CAC的日常实践的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号